Ansell Ltd ANN

Stock XASX Rating as of Oct 23, 2026

A$46.27 +0.51 (1.11%)

View Full Chart

As of Oct 23, 2026, 5:10:27 AM Delayed Price Closed

Company Report

View Archive

Mix Shift to Higher-Margin Healthcare Sales Underpins EBIT Margin Growth

Esther Holloway Aug 25, 2026

Ansell’s strategic focus is on growing market share in niche markets across industrial and healthcare settings. We think this strategy is appropriate, given a less competitive environment in niche markets, where product innovation and regulatory requirements raise barriers to entry, and an ability to achieve better margins from these sales.

Read Analysis

Price vs Fair Value

View History

ANN is trading at a LOCK|zyl premium.

Price

A$46.27

Oct 23, 2026

Fair Value

Aug 25, 2026

Uncertainty

LOCK|^G&#Q

1-Star Price: LOCK|.?v
5-Star Price: LOCK|.R
Economic Moat: LOCK|&#^
Capital Allocation: LOCK|q<%@Y?B

Bulls Say, Bears Say

Bulls

Expansion in clean room and surgical, a niche where Ansell’s products are more differentiated, earns materially higher margins than its other businesses, supporting group margin growth.

Bears

Cost pressures such as tariffs and supply chain disruptions weigh on operations, without certainty that price pass-throughs will succeed.

Trading Information

Previous Close Price: A$45.76
Day Range: A$45.42–46.27
52-Week Range: A$25.05–46.50
Bid/Ask: A$45.40 / A$46.45
Shares Outstanding: 140.72M
Market Cap: A$6.51B
Volume/Avg: 1M / 579,802

Key Statistics

Price/Earnings (Normalized): 16.24
Price/Sales: 2.11
Dividend Yield (Trailing): 2.07%
Dividend Yield (Forward): 2.50%
Dividend Payment Schedule: Mar, Sep
Total Yield: 5.14%

Company Profile

Ansell is a leading supplier of protective gloves and other wearable PPE for use in healthcare and industrial settings, each contributing about 50% of revenue. Industrial contributes slightly higher EBIT owing to higher margins. The company holds more than 500 patents, and most sales come from its key branded product ranges. Products are sold in about 100 countries, mostly via distributors. Approximately half of revenue is from North America, and about one-third is from Europe, the Middle East, and Asia. Latin America and Asia-Pacific each contribute about 10%.

Sector: Healthcare
Industry: Medical Instruments & Supplies
Stock Style Box: Mid Core
Total Number of Employees: 46,758
Website: https://www.ansell.com

Competitors

Valuation

Metric	ANN	RKT	BDX
Price/Earnings (Normalized)	16.24	20.37	15.30
Price/Book Value	2.23	6.20	2.22
Price/Sales	2.11	2.64	2.81
Price/Cash Flow	13.17	14.81	15.01

Price/Earnings

ANN

RKT

BDX

Financial Strength

Metric	ANN	RKT	BDX
Quick Ratio	1.14	0.38	0.36
Current Ratio	2.30	0.59	0.94
Interest Coverage	7.09	8.84	3.53

Quick Ratio

ANN

RKT

BDX

Profitability

Metric	ANN	RKT	BDX
Return on Assets (Normalized)	6.41%	9.05%	4.97%
Return on Equity (Normalized)	10.75%	33.99%	10.63%
Return on Invested Capital (Normalized)	8.69%	15.92%	7.26%

Return on Assets

ANN

RKT

BDX

Medical Instruments & Supplies Industry Comparables

Screen With Investor

Name	Capital Allocation	Economic Moat	Market Cap
Intuitive Surgical Inc ISRG	LOCK\|&@JN@Yxr	LOCK\|d%&	$160B
Becton Dickinson & Co BDX	LOCK\|X%s	LOCK\|F?Wj	$54B
ResMed Inc RMD	LOCK\|!r#sM&R	LOCK\|?@hm<	$36B
Alcon Inc ALC	LOCK\|J@zhqr	LOCK\|Cw^q	$34B
Medline Inc Ordinary Shares - Class A MDLN	LOCK\|<xxCvgd	LOCK\|>>kl	$30B
West Pharmaceutical Services Inc WST	LOCK\|Hn@Sb$>	LOCK\|%H^	$28B
Solventum Corp SOLV	LOCK\|H%RST%	LOCK\|N!	$15B
Baxter International Inc BAX	LOCK\|b<R	LOCK\|R>%kK	$13B
The Cooper Companies Inc COO	LOCK\|@s@MMS^	LOCK\|?RS!^	$12B
Repligen Corp RGEN	LOCK\|dp>C%X&	LOCK\|$$y>&	$11B